Appearing as a significant advance in the fight against obesity, this medication is attracting considerable buzz. This treatment combines properties of two recognized GLP-1 receptor agonists, semaglutide , and an additional glucose-dependent hormonal component. Preliminary clinical results have demonstrated significant fat reduction in individuals